The ticking time bomb: Cardiovascular diseases

Past event online

Health
starts
ends
Get in touch
Cardiovascular diseases: The ticking time bomb

About

Livestream begins at 18:00 CEST

As Europe gradually emerges out of the lockdown imposed to curb the COVID-19 outbreak, Friends of Europe explores how the EU can respond to the long-term impact of the crisis. A series of online debates looks at the impact of the pandemic on climate ambition, the economy, security and health systems.

The impact of COVID-19 on health systems is wide-ranging and extends beyond the consequences of the pandemic itself. Cardiovascular disease (CVD) patients, for example, are particularly vulnerable to COVID-19. Most have been avoiding the hospital out of fear of being infected, raising the question of whether we will see an increase in CVD deaths once the COVID-19 crisis subsides.

This online debate will explore policy options to ease the CVD burden on our health systems. Can investments in CVD technology and hospital infrastructure better prepare us for the next pandemic? What can be done to make early detection and treatment the standard for people at risk of CVD? A high-profile group of policymakers and key experts in the field will share their views and address questions from the online audience.


Our events include photos, audio and video recording that we might use for promotional purposes. By registering, you give your permission to use your image. Should you have any questions, please contact us.

PHOTO CREDIT: Bigstock

Schedule

Schedule

Participants connect online
The ticking time bomb: Cardiovascular diseases Expand The ticking time bomb: Cardiovascular diseases

From New York to Madrid, cardiologists are wondering where their patients are. While COVID-19 wards are packed, some hospitals report a drop of more than 50% in emergency procedures for heart attacks and strokes. COVID-19 poses a challenge to the entire population, but cardiovascular patients are particularly vulnerable to the disease. Doctors emphasise that they remain available for consultations, but not all cardiovascular patients are receiving the care they need as some planned surgeries have been cancelled and patients avoid the hospital out of fear of being infected.

Every year, cardiovascular diseases (CVD) cause over 1.8 million deaths – or 36% of the total number of deaths – in the European Union. Changing demographics will only exacerbate the situation. The outbreak of COVID-19 illustrates that the vulnerability of people over 70 suffering from comorbidities – in particular CVD – causes an unprecedented burden on our healthcare systems, economies and societies. If the EU is to turn the tide, taking a closer look at current and future challenges is a vital first step. When emerging from the crisis, the EU should consider investing in decreasing the vulnerability of the ageing population to lessen the burden for hospitals and healthcare systems. As the share of persons aged 65 years and older is projected to increase from 19% to 29% by 2050, early detection and treatment of CVD should become the standard. It is clear that CVD touch every citizen and policymakers should evaluate the instruments at hand to reduce the current and future burden.

  • What is needed to make CVD a focal point during this EU mandate?
  • Not every CVD patient in need of a hospital intervention is treated for their life-threatening condition today. What actions should be taken to avoid a rise in CVD deaths once the crisis subsides? What can be done to avoid this from happening during a next pandemic?
  • What can EU policymakers do to make early detection and treatment the standard for people at risk of CVD?

speakers

Brando Benifei

Member of the Internal Market and Consumer Protection Committee (IMCO) of the European Parliament and Co-Chair of the MEP Heart Group

Barbara Casadei

President of the European Society of Cardiology

Jean-Luc Lemercier

Corporate Vice President Europe, Middle East, Africa, Canada and Latin America regions of Edwards Lifesciences

Andrzej Rys

Director for Health Systems, Medical Products and Innovation at the European Commission Directorate-General for Health and Food Safety

Moderator

Tamsin Rose

Senior Fellow at Friends of Europe

End of debate
Speakers

Speakers

Brando Benifei
Brando Benifei

Member of the Internal Market and Consumer Protection Committee (IMCO) of the European Parliament and Co-Chair of the MEP Heart Group

Show more information on Brando Benifei

Brando Benifei is a Member of the European Parliament and Head of the Italian S&D MEP Delegation. Benifei is also the Co-Chair of the MEP Heart Group, where he works to raise cardiovascular diseases as a priority on the EU political agenda. A member of the Internal Market and Consumer Protection Committee (IMCO), he is rapporteur for the Single Market Programme and shadow rapporteur for the European Social Fund Plus. Benifei received the MEP Award for his work on employment, social affairs, and youth unemployment. Forbes included him in their 30 Under 30 Europe Policy Class of 2016.

Photo of Barbara Casadei
Barbara Casadei

President of the European Society of Cardiology

Show more information on Barbara Casadei

Barbara Casadei is a British Heart Foundation (BHF) Professor of Cardiovascular Medicine at the University of Oxford and President of the European Society of Cardiology since 2018. She is also an Honorary Consultant Cardiologist at the Oxford University Hospitals NHS Trust, where she leads the Cardiovascular Theme of the National Institute for Health Research (NIHR) Biomedical Research Centre. Her research programme focuses on understanding the cellular triggers and substrates of common cardiovascular diseases, such as heart failure and atrial fibrillation. Since 2013, Casadei has been a fellow of the UK Academy of Medical Sciences.

Jean-Luc-Lemercier
Jean-Luc Lemercier

Corporate Vice President Europe, Middle East, Africa, Canada and Latin America regions of Edwards Lifesciences

Show more information on Jean-Luc Lemercier

Jean-Luc Lemercier is the Corporate Vice President Europe, Middle East, Africa, Canada and Latin America regions of Edwards Lifesciences. Prior to assuming his current role, Lemercier served as the Vice President of transcatheter heart valves EMEA. Under his leadership at Edwards, the company successfully launched the SAPIEN transcatheter heart valve technology and built its leadership position in Europe. Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Lemercier also serves as Chair of the Cardiovascular Sector Group of MedTech Europe, the association representing the medical technology industry in Europe.

Andrzej Rys
Andrzej Rys

Director for Health Systems, Medical Products and Innovation at the European Commission Directorate-General for Health and Food Safety

Show more information on Andrzej Rys

Andrzej Rys has held several key positions in local and national health institutions, notably serving as the Director of the Health Department of the City of Kraków, President of the Polish Public Health Foundation and Polish Deputy Minister for Health, a role which put him on the negotiation team for Poland’s accession to the EU. He later founded and led the School of Public Health and the Centre for Innovation Technology Transfer at Jagiellonian University. In 2006, Rys joined the European Commission as the Director for Public Health and Risk Assessment and was later appointed Director for Health Systems, Medical Products and Innovation at the Directorate-General for Health and Food Safety, where he works on improving EU healthcare systems for citizens.

Photo of Tamsin Rose
Tamsin Rose

Senior Fellow at Friends of Europe

Show more information on Tamsin Rose

Tamsin Rose is Senior Fellow at Friends of Europe. Having studied international relations, she has 25 years of experience working across the European continent from Ireland to Mongolia. A natural communicator, Tamsin has been a radio reporter, worked on press for the EU Delegation in Moscow and is currently a member of the external speaker team for the European Commission Directorate General for Communication, describing how the EU works and key policies to visitor groups from around the world. Since 2002 she has specialised in public health and public participation issues, serving as Secretary General of the European Public Health Alliance (EPHA), and providing strategic advice for health groups on how to engage successfully with the EU.

Partners

Insights

view all insights

Next Event

view all events
Track title

Category

00:0000:00
Stop playback
Video title

Category

Close

We use cookies to improve your online experience.
For more information, visit our privacy policy